Ketoconazole and Ketoconazole/β-cyclodextrin performance on cotton wound dressing as fungal skin treatment

被引:31
|
作者
Hedayati, Nafiseh [1 ]
Montazer, Majid [1 ]
Mahmoudirad, Mahnaz [2 ]
Toliyat, Tayebeh [3 ]
机构
[1] Amirkabir Univ Technol, Amirkabir Nanotechnol Res Inst ANTRI, Funct Fibrous Struct & Environm Enhancement FFSEE, Text Engn Dept, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Skin Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Dept Pharmaceut, Fac Pharm, Tehran, Iran
关键词
Encapsulation; Ketoconazole; beta-Cyclodextrin; Drug delivery; Anti-fungal; Cross-linking agent; Cotton fabric; BETA-CYCLODEXTRIN; INCLUSION COMPLEXES; DRUG-DELIVERY; FIBERS; ANTIBACTERIAL; DISSOLUTION; DERIVATIVES; FORMULATION; ANTIFUNGAL; TOXICITY;
D O I
10.1016/j.carbpol.2020.116267
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Here, a cotton wound dressing was prepared with control release of Ketoconazole (KZ) to kill skin fungus. KZ alone and KZ/beta-cyclodextrin (beta-CD) were loaded on cotton through diverse methods. The drug release, antimicrobial activities against C. albicans, A. niger, E. coli and S. aureus and also cell cytotoxicity were studied. H-1 NMR ensured the formation of KZ/beta-CD complex, SEM images showed surface morphology and confirmed stability. KZ interestingly reacted with the cotton in the batch treatment possibly due to the two active chlorine groups, high temperature and relatively long treatment time. Good antifungal activities and slow release reported for the KZ treated fabric, however KZ/beta-CD loaded more on the fabric with regular and slow release for longer time. The batch performed better than continuous method indicated good antifungal activities with more KZ loading and slower release. Also a cross-linking agent along with beta-CD/KZ prolonged the release time with excellent washing stability.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] KETOCONAZOLE IN THE TREATMENT OF FUNGAL PERITONITIS
    JOHNSON, R
    BLAIR, A
    AHMAD, S
    PERITONEAL DIALYSIS BULLETIN, 1985, 5 (02): : 136 - 137
  • [2] KETOCONAZOLE - A MAJOR INNOVATION FOR TREATMENT OF FUNGAL DISEASE
    GRAYBILL, JR
    DRUTZ, DJ
    ANNALS OF INTERNAL MEDICINE, 1980, 93 (06) : 921 - 923
  • [3] Influence of proline and β-Cyclodextrin in ketoconazole physicochemical and microbiological performance
    Zoppi, Ariana
    Buhlman, Natalia
    Pablo Cerutti, Juan
    Longhi, Marcela R.
    Aiassa, Virginia
    JOURNAL OF MOLECULAR STRUCTURE, 2019, 1176 : 470 - 477
  • [4] Ketoconazole resistant Candida albicans is sensitive to a wireless electroceutical wound care dressing
    Khona, Dolly K.
    Roy, Sashwati
    Ghatak, Subhadip
    Huang, Kaixiang
    Jagdale, Gargi
    Baker, Lane A.
    Sen, Chandan K.
    BIOELECTROCHEMISTRY, 2021, 142
  • [5] RETENTION OF KETOCONAZOLE IN THE SKIN AFTER ORAL TREATMENT
    HANEKE, E
    HAUTARZT, 1987, 38 (02): : 93 - 96
  • [6] TREATMENT OF FUNGAL-INFECTIONS IN THE BONES AND JOINTS WITH KETOCONAZOLE
    HORSBURGH, CR
    CANNADY, PB
    KIRKPATRICK, CH
    JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (06): : 1064 - 1069
  • [7] COMBINED KETOCONAZOLE AND SURGICAL-TREATMENT OF FUNGAL MYCETOMA
    ANDREU, JM
    CHIRURGIE, 1986, 112 (02): : 163 - 169
  • [8] KETOCONAZOLE TREATMENT OF FUNGAL INFECTION IN ACUTE-RENAL-FAILURE
    NAKASATO, S
    SHAH, GM
    MORRISSEY, RL
    WINER, RL
    CLINICAL AND EXPERIMENTAL DIALYSIS AND APHERESIS, 1983, 7 (03): : 191 - 196
  • [9] Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole
    Che, Junxiu
    Wu, Zushuai
    Shao, Weiyan
    Guo, Penghao
    Lin, Yuanyuan
    Pan, Wenhui
    Zeng, Weidong
    Zhang, Guoguang
    Wu, Chuanbin
    Xu, Yuehong
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 93 : 136 - 148
  • [10] TREATMENT OF CENTRAL NERVOUS-SYSTEM FUNGAL INFECTION WITH KETOCONAZOLE
    GOODPASTURE, HC
    HERSHBERGER, RE
    BARNETT, AM
    PETERIE, JD
    ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (05) : 879 - 880